Home

RUBICON RESEARCH LIMITED

RUBICON.NSNSEHealthcare
₹1,658.00Today3.87% · +₹61.70
Day rangeTrading above day high
₹0.00₹0.00
Open
₹0.00
Prev close
₹1,596.30
AskWarren SignalsUpdated 21:38 IST
Momentum Bullish(+3.87% today)Volume 134% Above Avg52W Position Near 52W High
Volume
5.7L
134% above avg
Avg vol (20D)
2.4L
20-day baseline
Mkt cap
₹27,372.5Cr
Mid Cap
P/E TTM
104.8×

Trade RUBICON RESEARCH LIMITED with Artha

Sign in to place orders, set alerts, and sync your watchlist.

Sign in to trade

Rubicon Research Limited operates as a specialty pharmaceutical company in India, the United States, and internationally. The company develops products in the areas of analgesics/pain management, cardiovascular system, central nervous system, hypokalemia, skeletal muscle relaxants, nicotine replacement therapy, gastrointestinal, metabolic, and immunosuppressant. Its primary proprietary technologies for drug delivery comprising RubiReten, a gastro-retentive system for drugs with poor solubility and a limited window of absorption, as well as RubiSRL for the formulation of sustained release liquids using a combination of ion exchange and membrane diffusion controlled-release technologies. The company was incorporated in 1999 and is headquartered in Mumbai, India.

Classification

SectorHealthcare
IndustryDrug Manufacturers - General
Stock ExchangeNSE

Identifiers

Ticker SymbolRUBICON.NS

Company Info

HeadquartersNot available
Employees1,290
Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades
Create free account

We use analytics cookies to understand how you use Artha and improve your experience. No data is sold to third parties.